Trials / Conditions / Acute Myeloid Leukemia (AML) Relapse
Acute Myeloid Leukemia (AML) Relapse
3 registered clinical trials studyying Acute Myeloid Leukemia (AML) Relapse — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | A Phase I Single-arm Clinical Study of Donor NK Cells Infusion Combined with Low-dose Interleukin-2 in the Tre NCT06641648 | Peking University First Hospital | Phase 1 |
| Completed | Association of Ex Vivo Drug Response ( EVDR) and Clinical Outcome in Acute Myeloid Leukaemia (EXCYTE-2) NCT06648512 | Exscientia AI Limited | — |
| Completed | Trial to Find and Investigate a Safe Dose of F16IL2 and BI 836858 in Patients With AML Relapse After Allogenei NCT03207191 | Philogen S.p.A. | Phase 1 |